<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the expression of SNCG in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and its clinical significance </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Surgical specimens were collected from 217 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients with complete clinical and follow up data between January 1999 and December 2003 </plain></SENT>
<SENT sid="2" pm="."><plain>There were 113 cases with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and 104 without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>SNCG expression was identified by immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>Association of SNCG expression with clinicopathologic factors and prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was accessed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The positive rate of SNCG in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with and without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> was 68.1% and 27.9%, respectively, and the difference was statistically significant(P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Logistic regression analysis showed that SNCG expression was an independent factor associated with the presence of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>(OR=8.29, 95%CI: 3.37-20.37, P&lt;0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>In synchronous colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, the median survival time of SNCG-negative and SNCG-positive was 12.6 months and 8.2 months, respectively(Log Rank, P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Multivariate Cox analysis showed that SNCG expression was an independent prognostic factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with synchronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>(RR=1.97, 95%CI:1.10-3.53, P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: High expression of SNCG is present in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue in patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>SNCG may be used as a predictive biomarker for colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and is an important prognostic factor in patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>